PRKN and ovarian carcinoma: It binds to and acetylates COP1 at K294, which impairs the function of COP1 as an E3 ubiquitin ligase and leads to the accumulation and enhanced activity of β-catenin, thereby promoting the proliferation and migratory ability of ovarian cancer cells.182